PATENT CLAIM ANALYSIS

Application Number: 16098262
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-04
Patent Classification: ["514", "255050"]

Abstract:
The present invention relates to novel 5-(carboxamide)-1-aryl-1,2,4-triazole derivatives, to processes for the preparation of such compounds, to pharmaceutical compositions containing such compounds, and to the use of such compounds or compositions for the treatment and/or prevention of diseases, in particular for the treatment and/or prevention of renal and cardiovascular diseases.

Claim (Index 3):
A compound of general formula (I) according to  claim 1 ,\n wherein R 1  represents a group of the formula in which # 1  represents the point of attachment to the nitrogen atom, Ar represents a group of the formula in which # 1  represents the point of attachment to the nitrogen atom, R 2A  represents a group selected from a chlorine atom, a bromine atom, isopropyl, and nitro, R 3G  represents a group selected from a chlorine atom and methyl, or a pharmaceutically acceptable salt, hydrate and/or solvate thereof.

Metadata:
- Claim Count in Document: 32.0
- Percentile: 98.0
- Lexical Diversity: 1.68571
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['16098255', '15581064', '15969222', '13819885', '16098202']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7929461994950818
- 35 USC 102 Novelty (BERT): 0.5994757974750927
- Combined Prediction Score: 0.773599159293083
- Mean Citation Score: 423.403306
- Max Citation Score: 520.59686
- Similarity Product: 447.9675047327447

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test